Juliette Lambert - Concepedia

Author

Juliette Lambert

Also Known As

Caroline Besson, Corentin Orvain, Delphine Lebon, Felipe Suarez, J F Lambert, J Lambert, J. Lambert, Juliette Lambert, Lauris Gastaud, Sylvain Chantepie

Publications

1.4K

Citations

H-Index

Concepts

All Affiliations

Centre Hospitalier de Versailles Hôpital Saint-Louis Inserm Assistance Publique – Hôpitaux de Paris Université Paris Cité

About

Juliette Lambert is an author at Centre Hospitalier de Versailles specializing in cancer research, medicine, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	3	133
2	Cancer Research	2	3	133
3	Immunology	1	1	15
4	Pathology	1	1	15
5	Immunotherapy	1	1	15

Juliette Lambert

Publications

1.1K

Citations

H-Index

Page 1

	Year	Citations
Gemtuzumab ozogamicin for <i>de novo</i> acute myeloid leukemia: final efficacy and safety updates from the open-label, phase III ALFA-0701 trial Juliette Lambert, Cécile Pautas, Christine Terré, Haematologica	2018	336
Assessment of global longitudinal strain at low-dose anthracycline-based chemotherapy, for the prediction of subsequent cardiotoxicity C. Charbonnel, R. Convers-Domart, Sophie Rigaudeau, European Heart Journal - Cardiovascular Imaging	2016	106
Mutational profile and benefit of gemtuzumab ozogamicin in acute myeloid leukemia Élise Fournier, Nicolas Duployez, Benoît Ducourneau, Blood	2019	82
MRD assessed by<i>WT1</i>and<i>NPM1</i>transcript levels identifies distinct outcomes in AML patients and is influenced by gemtuzumab ozogamicin Juliette Lambert, Jérôme Lambert, Olivier Nibourel, Oncotarget	2014	80
Added prognostic value of secondary AML-like gene mutations in ELN intermediate-risk older AML: ALFA-1200 study results Claude Gardin, Cécile Pautas, Élise Fournier, Blood Advances	2020	80
Prognostic impact of<i>DDX41</i>germline mutations in intensively treated acute myeloid leukemia patients: an ALFA-FILO study Nicolas Duployez, Laëtitia Largeaud, Matthieu Duchmann, Blood	2022	75
Involvement of the Tpl-2/cot oncogene in MMTV tumorigenesis. J. Péli, Juliette Lambert, V Müller, PubMed	1996	62
Prognostic significance of concurrent gene mutations in intensively treated patients with<i>IDH</i>-mutated AML: an ALFA study Matthieu Duchmann, Jean‐Baptiste Micol, Nicolas Duployez, Blood	2021	60
Assessment of global longitudinal strain at low-dose anthracycline-based chemotherapy for the prediction of subsequent cardiotoxicity C. Charbonnel, R. Convers-Domart, Sophie Rigaudeau, Annales de Cardiologie et d Angéiologie OncologySubsequent CardiotoxicityCardiovascular ToxicityMedicineRadiation Oncology	2016	59
A personalized approach to guide allogeneic stem cell transplantation in younger adults with acute myeloid leukemia Laurène Fenwarth, Xavier Thomas, Stéphane de Botton, Blood	2020	50

Page 1